AVG.STU Avantor Inc

Healthcare Chemicals Stuttgart Exchange
14.29 EUR
Close of Nov 1, 2026
6.40 15.57
Market cap
EUR 9.68B
P/E
33.6x
P/B
1.86x
ROE
6.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is AVG.STU undervalued?

Graham number
Price14.29
Graham value8.59
Premium66.4%

AVG.STU trades 66.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Avantor Inc fundamental analysis

No fundamental analysis for Avantor Inc yet.

Avantor Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Avantor Inc

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chrom…

Full company profile